U.S. physicians are losing trust in the FDA and CDC, presenting a new challenge — and opportunity — for device developers and ...

The agency declined to quickly release documents that would identify drugs made at some of the most troubled foreign factories. The request was part of ProPublica’s ongoing investigation into the ...

These ASX 200 stocks could be among the best to buy now according to analysts at Bell Potter. Here's why it is bullish on ...

Our fair value estimate for Philips is EUR 35 per share. While the litigation settlement is an important milestone, the company continues to operate under the consent decree, preventing it from ...

The powerful Inspiration Elite is the newest and lightest compressor nebulizer system in the Respironics family is here. It's durable, easy to use and easy to maintain. But best of all, it ...

Currently, obstructive sleep apnea (OSA) is the second most common sleep disorder and affects almost one billion adults globally,1 causing more patients to turn to CPAP therapy as part of their ...

There are several different approaches to treating sleep apnea that include surgical procedures and oral appliances. Continuous positive airway pressure (CPAP), for example, requi ...

Obstructive sleep apnea is still largely undiagnosed and untreated. In a growing marketplace of solutions, can negative ...

The global sleep screening devices market is estimated to be valued at USD 10,579.3 million in 2025 and is projected to reach USD 20,617.5 million by 2035, registering a CAGR of 6.9% over the forecast ...